Lexpos News

Registration for the new Children’s Flu Vaccination Service for children aged 2-3 years is now open on the NHS Business Services Authority’s Manage Your Service (MYS) portal. As announced last week, this is one-season trial of the new Advanced service and pharmacy owners that choose to provide the service will be able to commence vaccinating eligible [...]

The post Children’s Flu Vac: Registration has now opened appeared first on Community Pharmacy England.

Changes are being made to the Manage Your Service (MYS) pharmacy portal, aimed at improving user experience. The new-look portal will be launched on Thursday 21 August 2025. Please note: the MYS portal will be temporarily unavailable between 7:00am to 8:30am on Thursday 21 August 2025 whilst NHS Business Services Authority (NHSBSA) make the changes. The [...]

The post Upcoming changes to the MYS Portal appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Olmesartan medoxomil 10mg film-coated tablets (Jubilant Pharmaceuticals NV) Date issued: 31 July 2025 Drug Alert Number: EL(25)A/37 Jubilant Pharmaceuticals NV has informed the MHRA that the Patient Information leaflet (PIL) in the cartons for the batches listed in this notification include an outdated PIL. DMRC reference number: DMRC-34866997 Marketing Authorisation [...]

The post MHRA Class 4 Medicines Defect Notification: Olmesartan medoxomil 10mg film-coated tablets (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (31/07/2025) confirmed the following final list of price concessions for July 2025.  Drug Pack size Price concession Acetazolamide 250mg tablets 112 £60.90 Amiodarone 100mg tablets 28 £2.02 Buprenorphine 8mg sublingual tablets sugar free 7 £5.05 Carbocisteine 250mg/5ml oral solution 300 £4.99 Carbocisteine 375mg capsules 120 £2.75 [...]

The post July 2025 Price Concessions Final Update appeared first on Community Pharmacy England.

National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment National Patient Safety Alert Reference Number: NatPSA/2025/004/MVA Date issued: 29 July 2025 Explanation of identified issue: The following antimicrobial medicines used to treat tuberculosis (TB) will be intermittently available until at least the end of 2025: Rifampicin 150mg and 300mg capsules Rifampicin [...]

The post National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment appeared first on Community Pharmacy England.